Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nanoscale anisotropic plastic deformation in single crystal GaN.
Huang J, Xu K, Fan YM, Niu MT, Zeng XH, Wang JF, Yang H. Huang J, et al. Among authors: zeng xh. Nanoscale Res Lett. 2012 Feb 22;7(1):150. doi: 10.1186/1556-276X-7-150. Nanoscale Res Lett. 2012. PMID: 22353389 Free PMC article.
Dark Matter Results from First 98.7 Days of Data from the PandaX-II Experiment.
Tan A, Xiao M, Cui X, Chen X, Chen Y, Fang D, Fu C, Giboni K, Giuliani F, Gong H, Guo X, Han K, Hu S, Huang X, Ji X, Ju Y, Lei S, Li S, Li X, Li X, Liang H, Lin Q, Liu H, Liu J, Lorenzon W, Ma Y, Mao Y, Ni K, Ren X, Schubnell M, Shen M, Shi F, Wang H, Wang J, Wang M, Wang Q, Wang S, Wang X, Wang Z, Wu S, Xiao X, Xie P, Yan B, Yang Y, Yue J, Zeng X, Zhang H, Zhang H, Zhang H, Zhang T, Zhao L, Zhou J, Zhou N, Zhou X; PandaX-II Collaboration. Tan A, et al. Phys Rev Lett. 2016 Sep 16;117(12):121303. doi: 10.1103/PhysRevLett.117.121303. Epub 2016 Sep 16. Phys Rev Lett. 2016. PMID: 27689262
Comparing the Robustness of Intensity-modulated Proton Therapy and Proton-arc Therapy Against Interplay Effects of 4D Robust-optimised Plans for Lung Stereotactic Body Radiotherapy.
Wei WG, Yu H, Xiao Q, Li ZB, Li J, Zhang XY, Wu YC, Qin TL, Zeng XH, Song Y, Li GJ, Bai S. Wei WG, et al. Among authors: zeng xh. Clin Oncol (R Coll Radiol). 2025 Jan 4;39:103757. doi: 10.1016/j.clon.2025.103757. Online ahead of print. Clin Oncol (R Coll Radiol). 2025. PMID: 39847967
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
He M, Jiang YZ, Gong Y, Fan L, Liu XY, Liu Y, Tang LC, Mo M, Hou YF, Di GH, Liu GY, Yu KD, Wu J, Yan X, Zeng XH, Fu DY, Song CG, Zhuang ZG, Wu KJ, Wang J, Wang ZH, Shao ZM. He M, et al. Among authors: zeng xh. BMJ. 2024 Oct 23;387:e079603. doi: 10.1136/bmj-2024-079603. BMJ. 2024. PMID: 39442958 Free PMC article. Clinical Trial.
204 results